Gleeson N - Search Results

1

Potential role of miR-9 and miR-223 in recurrent ovarian cancer.

Laios A, O'Toole S, Flavin R, Martin C, Kelly L, Ring M, Finn SP, Barrett C, Loda M, Gleeson N, D'Arcy T, McGuinness E, Sheils O, Sheppard B, O' Leary J. Laios A, et al. Among authors: gleeson n. Mol Cancer. 2008 Apr 28;7:35. doi: 10.1186/1476-4598-7-35. Mol Cancer. 2008. PMID: 18442408 Free PMC article.

2

The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding.

Gleeson NC, Buggy F, Sheppard BL, Bonnar J. Gleeson NC, et al. Acta Obstet Gynecol Scand. 1994 Mar;73(3):274-7. doi: 10.3109/00016349409023453. Acta Obstet Gynecol Scand. 1994. PMID: 8122512

3

Cyclical variation in endometrial oestrogen and progesterone receptors in women with normal menstruation and dysfunctional uterine bleeding.

Gleeson N, Jordan M, Sheppard B, Bonnar J. Gleeson N, et al. Eur J Obstet Gynecol Reprod Biol. 1993 Mar;48(3):207-14. doi: 10.1016/0028-2243(93)90089-u. Eur J Obstet Gynecol Reprod Biol. 1993. PMID: 8335139

4

Whole blood platelet aggregation in moderate and severe pre-eclampsia.

Norris LA, Gleeson N, Sheppard BL, Bonnar J. Norris LA, et al. Among authors: gleeson n. Br J Obstet Gynaecol. 1993 Jul;100(7):684-8. doi: 10.1111/j.1471-0528.1993.tb14239.x. Br J Obstet Gynaecol. 1993. PMID: 8369255

5

Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding.

Gleeson N, Devitt M, Sheppard BL, Bonnar J. Gleeson N, et al. Br J Obstet Gynaecol. 1993 Aug;100(8):768-71. doi: 10.1111/j.1471-0528.1993.tb14272.x. Br J Obstet Gynaecol. 1993. PMID: 8399019

6

Serous papillary adenocarcinomas of the ovary display heterogeneity in their response to chemotherapy.

O'Toole SA, Sheppard BL, McGuinness E, Gleeson NC, Bonnar J. O'Toole SA, et al. Among authors: gleeson nc. Int J Gynecol Cancer. 2001 Sep-Oct;11(5):365-71. doi: 10.1046/j.1525-1438.2001.01041.x. Int J Gynecol Cancer. 2001. PMID: 11737467

7

The MTS assay as an indicator of chemosensitivity/resistance in malignant gynaecological tumours.

O'Toole SA, Sheppard BL, McGuinness EP, Gleeson NC, Yoneda M, Bonnar J. O'Toole SA, et al. Cancer Detect Prev. 2003;27(1):47-54. doi: 10.1016/s0361-090x(02)00171-x. Cancer Detect Prev. 2003. PMID: 12600417

8

An integrative model for recurrence in ovarian cancer.

Laios A, O'Toole SA, Flavin R, Martin C, Ring M, Gleeson N, D'Arcy T, McGuinness EP, Sheils O, Sheppard BL, O' Leary JJ. Laios A, et al. Among authors: gleeson n. Mol Cancer. 2008 Jan 22;7:8. doi: 10.1186/1476-4598-7-8. Mol Cancer. 2008. PMID: 18211683 Free PMC article. No abstract available.

9

Pre-Treatment of platinum resistant ovarian cancer cells with an MMP-9/MMP-2 inhibitor prior to cisplatin enhances cytotoxicity as determined by high content screening.

Laios A, Mohamed BM, Kelly L, Flavin R, Finn S, McEvoy L, Gallagher M, Martin C, Sheils O, Ring M, Davies A, Lawson M, Gleeson N, D'Arcy T, d'Adhemar C, Norris L, Langhe R, Saadeh FA, O'Leary JJ, O'Toole SA. Laios A, et al. Among authors: gleeson n. Int J Mol Sci. 2013 Jan 22;14(1):2085-103. doi: 10.3390/ijms14012085. Int J Mol Sci. 2013. PMID: 23340649 Free PMC article.

10

Venous thromboembolism in ovarian cancer: incidence, risk factors and impact on survival.

Abu Saadeh F, Norris L, O'Toole S, Gleeson N. Abu Saadeh F, et al. Among authors: gleeson n. Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):214-8. doi: 10.1016/j.ejogrb.2013.06.004. Epub 2013 Jul 2. Eur J Obstet Gynecol Reprod Biol. 2013. PMID: 23830352

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters